European HealthTech and MedTech Lower to Mid Market M&A 2030: The Future of Healthcare Technology Investment Banking

The European healthcare technology (HealthTech) and medical technology (MedTech) sectors have entered an era of industrial maturity, marking a definitive departure from the speculative, volume-driven dealmaking of the post-pandemic cycle. Characterized by market analysts as "The Great Rationalisation," current market dynamics reflect a flight to quality where top-line revenue growth is no longer evaluated as an isolated proxy for enterprise value. Asset valuations and transaction velocity are dictated by demonstrated clinical pathway integration, regulatory fortification under expanding European Union frameworks, margin sustainability, and measurable return on investment (ROI) for fiscally constrained health systems.
  
Between 2025 and 2030, the European HealthTech market is projected to expand from $96.68 billion to $222.22 billion, representing a compound annual growth rate (CAGR) of 18.11%. Concurrently, the European MedTech market stands at approximately €170 billion, maintaining a resilient positive net medical device trade balance of €5 billion. Despite macroeconomic volatility, capital deployment has surged. Transaction value in European healthcare and life sciences reached €31.8 billion in the first half of 2025 alone—an 87% increase year-over-year—despite an 8% decline in total deal count. This pivot toward "bigger cheques, fewer bets" highlights how financial sponsors and strategic acquirers are concentrating capital on high-conviction, cash-generative platform assets.

Private equity (PE) has established itself as the primary engine of transaction activity across the European lower-to-mid market. Sponsor buyout deployment in European healthcare expanded by 276% year-over-year to €29.6 billion, fuelled by substantial dry powder reserves, private credit stabilisation and aggressive buy-and-build consolidation strategies. As corporate M&A volumes gradually stabilise, sponsors are actively consolidating fragmented lower-to-mid market providers, deploying operational transformation, back-office automation, and cross-border digital integration to execute multiple arbitrage strategies.

Read the report in full https://www.healthcare.digital/single-post/european-healthtech-and-medtech-lower-to-mid-market-m-a-2030-the-future-of-healthcare-technology-in